Financial Reports Latest Updates Industry Maps Economic Calendar

UNIVERSAL HEALTH REALTY INCOME TRUST (UHT) Annual Reports

Q: Where can I read UNIVERSAL HEALTH REALTY INCOME TRUST (UHT) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

UNIVERSAL HEALTH REALTY INCOME TRUST is listed on NYSE, classified by the SEC under Real Estate Investment Trusts (SIC 6798). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： NYSE
Fiscal year end： 12/31
SEC CIK： 798783 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$25.0M	$24.9M	+0.5%
Operating income	$9.2M	$8.8M	+4.1%
Net income	$5.9M	$4.5M	+31.5%
EPS (diluted)	$0.43	$0.32	+34.4%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 25.0 mn Net income 5.91 mn

Show table：Income statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	31.9	7.47	7.17	6.59	6.68	6.77	7.39	8.66	13.3	13.7	13.6	13.3	13.9	13.5	13.4	13.4	14.3	14.3	15.3	15.9	16.2	16.1	15.7	16.0	16.2	16.5	16.8	17.6	17.8	18.1	18.2	18.3	18.5	2.20	2.50	18.7	2.20	19.3	19.9	18.9	19.2	19.3	19.7	19.8	20.7	20.9	21.2	21.4	22.2	22.2	22.1	24.1	23.2	23.8	24.2	24.3	25.1	24.7	24.5	24.6	24.6	24.9	25.3	24.5	24.5	25.0
Operating income	17.9	3.96	3.61	3.44	3.73	3.33	3.19	-1.53	3.61	3.82	4.22	4.72	4.75	4.40	4.59	4.80	4.86	4.74	4.70	4.75	5.23	4.60	5.09	5.71	5.54	5.53	5.08	5.96	5.96	6.00	6.11	5.97	6.14	7.61	6.50	6.46	6.22	6.59	6.86	6.08	6.43	6.30	6.64	6.64	7.25	6.93	7.29	7.39	7.38	7.24	7.32	8.73	7.79	7.38	8.03	8.15	9.46	9.58	8.49	9.26	9.03	8.84	8.39	8.49	8.96	9.20
Net income	18.6	4.27	3.39	4.12	4.13	3.69	3.35	62.6	9.51	2.47	2.99	4.51	3.43	2.94	3.30	3.50	3.77	3.41	28.1	16.2	3.70	12.0	3.64	4.35	4.43	4.52	3.82	4.45	31.6	4.03	3.96	6.06	9.60	5.81	4.37	4.41	4.21	4.26	4.65	5.84	4.55	4.70	5.19	5.00	5.59	6.62	5.34	91.6	5.41	5.22	4.85	5.63	4.46	3.48	3.87	3.59	5.30	5.28	4.00	4.66	4.78	4.49	4.02	4.32	5.02	5.91

Balance sheet

Quarterly · In mn (USD)

Total assets 567 mn Total liabilities 423 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Total assets	—	—	—	216	—	228	243	371	395	391	388	383	380	381	375	373	388	384	437	429	442	444	439	459	471	487	510	525	502	500	499	490	490	491	488	484	489	483	484	489	489	487	491	494	496	504	518	598	602	604	609	608	604	603	608	596	596	587	584	581	573	573	568	565	564	567
Total liabilities	—	—	—	70.6	—	89.5	109	182	205	205	207	205	206	212	211	208	224	224	257	224	242	241	239	264	280	287	315	333	288	291	286	279	278	283	284	285	295	294	299	307	317	320	328	335	337	349	366	363	365	369	376	378	382	386	398	395	400	396	403	401	401	408	409	413	416	423
Equity	141	—	—	145	—	138	134	189	191	186	181	178	173	169	164	166	164	159	179	205	200	204	199	195	191	200	195	191	214	209	213	211	211	208	203	199	194	189	185	182	172	166	162	159	159	155	152	235	237	235	234	229	222	217	210	201	196	191	182	180	172	165	159	152	148	144

Cash flow

Quarterly · In mn (USD)

Operating 12.4 mn Investing -7.84 mn Financing -4.81 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	25.0	12.3	5.33	5.41	5.17	5.16	5.47	5.58	7.01	7.61	7.83	8.34	7.62	8.03	7.35	8.29	6.97	8.33	8.59	8.91	8.23	9.59	9.49	10.9	9.09	10.9	9.74	11.0	9.49	10.8	13.3	12.4	10.8	12.4	10.0	9.69	8.63	12.8	10.3	10.9	10.1	13.1	9.57	11.4	11.3	14.2	10.8	11.5	11.7	13.2	9.58	12.3	10.1	12.3	10.2	10.5	11.7	12.1	9.89	13.2	11.6	13.7	10.2	13.6	11.9	12.4
Investing	-12.4	-15.4	-3.10	1.21	-6.93	-7.41	-15.3	26.4	-7.12	-0.66	-1.20	0.42	-0.7	-5.86	-5.57	-1.38	-7.90	-1.02	-10.2	15.0	-20.5	0.91	-0.33	-24.4	-16.8	-20.2	-27.2	-10.6	42.3	8.76	-11.5	-0.09	2.18	-6.00	-2.68	-1.46	-1.84	-1.12	-4.91	-8.60	-6.99	-4.32	-5.48	-10.4	-12.2	-11.0	-17.9	16.7	-18.3	-7.48	-5.44	-5.43	-5.41	-3.48	-11.0	0.74	-8.94	-0.72	-1.50	-2.71	-1.90	-8.79	-1.75	-2.52	-4.46	-7.84
Financing	-10.2	1.30	-2.41	-6.69	1.74	2.02	9.93	-21.1	-7.75	-7.52	-6.68	-8.87	-6.64	-2.39	-1.80	-6.65	1.18	-7.30	0.13	-23.8	12.3	-10.1	-9.85	13.8	8.11	9.71	16.7	-0.42	-51.6	-8.32	-13.2	-12.8	-12.1	-4.92	-8.01	-8.27	-5.80	-11.7	-4.93	-2.72	-3.59	-8.07	-4.11	-1.60	1.40	0.44	6.73	-15.1	-7.01	-6.24	-4.43	-7.35	-4.15	-7.43	-0.31	-11.3	-3.31	-13.5	-7.60	-9.72	-9.84	-5.32	-8.09	-11.3	-7.11	-4.81
Cash at period end	3.04	1.25	1.06	0.99	0.96	0.74	0.79	11.7	3.79	3.21	3.15	3.05	3.32	3.10	2.94	3.34	3.84	3.86	3.74	3.86	3.95	4.35	3.65	3.89	4.32	4.71	3.98	3.93	4.07	4.11	3.95	3.39	4.21	5.73	5.07	5.04	6.03	6.07	6.52	6.11	5.67	6.34	6.32	5.74	6.17	9.73	9.35	22.5	8.88	8.40	8.10	7.61	8.12	9.46	8.36	8.21	7.70	5.58	6.37	7.10	6.97	6.55	6.92	6.69	7.06	6.82

Profitability

Quarterly · %

Operating margin 36.8% Net margin 23.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating margin	56.2%	53.0%	50.3%	52.2%	55.9%	49.3%	43.2%	-17.6%	27.0%	27.9%	31.0%	35.4%	34.2%	32.6%	34.1%	35.7%	34.0%	33.1%	30.8%	29.8%	32.3%	28.7%	32.5%	35.6%	34.1%	33.6%	30.3%	33.9%	33.6%	33.0%	33.6%	32.7%	33.1%	345.8%	260.1%	34.5%	282.9%	34.1%	34.5%	32.2%	33.5%	32.7%	33.7%	33.5%	35.0%	33.2%	34.4%	34.5%	33.3%	32.7%	33.0%	36.2%	33.5%	31.0%	33.1%	33.5%	37.6%	38.8%	34.7%	37.6%	36.8%	35.6%	33.2%	34.7%	36.5%	36.8%
Net margin	58.2%	57.2%	47.2%	62.5%	61.8%	54.6%	45.3%	723.3%	71.3%	18.1%	21.9%	33.9%	24.7%	21.8%	24.6%	26.0%	26.4%	23.8%	184.4%	101.9%	22.8%	74.8%	23.2%	27.2%	27.3%	27.5%	22.7%	25.3%	177.8%	22.2%	21.8%	33.2%	51.8%	263.9%	175.0%	23.6%	191.4%	22.1%	23.4%	31.0%	23.7%	24.4%	26.4%	25.2%	27.0%	31.7%	25.2%	427.9%	24.4%	23.5%	21.9%	23.3%	19.2%	14.6%	16.0%	14.8%	21.1%	21.3%	16.3%	18.9%	19.5%	18.1%	15.9%	17.7%	20.5%	23.6%

Returns & leverage

Quarterly · %

ROE 12.5% ROA 3.4% Debt ratio 74.6%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	20.9%	—	11.1%	11.4%	44.1%	41.5%	48.1%	49.3%	10.6%	7.3%	7.8%	8.2%	7.7%	8.0%	8.5%	22.6%	27.9%	28.3%	33.1%	18.8%	11.9%	12.5%	8.4%	8.7%	8.9%	21.9%	21.4%	21.5%	22.7%	11.1%	12.2%	12.4%	11.8%	9.3%	8.7%	9.0%	10.0%	10.6%	11.1%	11.7%	11.4%	12.4%	13.9%	14.3%	55.4%	55.1%	55.2%	55.6%	9.1%	8.8%	8.2%	7.9%	7.2%	7.8%	8.9%	9.3%	10.1%	10.2%	10.1%	10.6%	10.6%	11.2%	12.5%
ROA	—	—	—	14.1%	—	6.7%	6.3%	25.1%	20.0%	25.2%	24.6%	5.2%	3.5%	3.6%	3.7%	3.5%	3.5%	3.7%	9.6%	12.9%	12.4%	14.5%	8.1%	5.3%	5.3%	3.6%	3.6%	3.5%	9.1%	8.9%	8.7%	9.0%	4.8%	5.1%	5.2%	5.0%	3.8%	3.5%	3.6%	3.9%	4.0%	4.1%	4.2%	4.0%	4.2%	4.5%	4.5%	20.0%	19.9%	19.4%	19.0%	3.5%	3.3%	3.0%	2.9%	2.6%	2.7%	3.0%	3.0%	3.3%	3.2%	3.1%	3.1%	3.1%	3.1%	3.4%
Debt ratio	—	—	—	32.7%	—	39.3%	44.8%	49.1%	51.7%	52.5%	53.3%	53.6%	54.3%	55.7%	56.3%	55.6%	57.8%	58.5%	58.9%	52.3%	54.7%	54.2%	54.6%	57.5%	59.4%	58.9%	61.7%	63.5%	57.4%	58.2%	57.3%	57.0%	56.8%	57.6%	58.3%	58.9%	60.4%	60.9%	61.8%	62.8%	64.8%	65.8%	66.9%	67.8%	68.0%	69.2%	70.7%	60.7%	60.7%	61.1%	61.7%	62.3%	63.2%	64.1%	65.4%	66.3%	67.0%	67.5%	68.9%	69.1%	70.0%	71.2%	72.1%	73.0%	73.8%	74.6%

EPS

Quarterly · US$

EPS US$0.43

Show table：EPS

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	1.56	0.35	0.27	0.33	0.33	0.29	0.26	4.95	0.75	0.19	0.24	0.36	0.27	0.23	0.26	0.27	0.29	0.26	2.18	1.24	0.28	0.90	0.27	0.33	0.33	0.34	0.28	0.33	2.32	0.30	0.29	0.44	0.70	0.42	0.32	0.32	0.31	0.31	0.34	0.42	0.33	0.34	0.38	0.36	0.41	0.48	0.39	6.65	0.39	0.38	0.35	0.41	0.32	0.25	0.28	0.26	0.38	0.38	0.29	0.34	0.34	0.32	0.29	0.31	0.36	0.43

Revenue & profit

Year-to-date · In mn (USD)

Revenue 49.5 mn Net income 10.9 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 567 mn Total liabilities 423 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating 24.4 mn Investing -12.3 mn Financing -11.9 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Operating margin 36.7% Net margin 22.1%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE 12.5% ROA 3.4% Debt ratio 74.6%

EPS

Year-to-date · US$

EPS US$0.79

Revenue & profit

Annual · In mn (USD)

Revenue 99.2 mn Net income 17.6 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	29.5	54.0	54.3	59.8	64.0	67.1	72.3	42.0	60.3	78.0	84.2	90.6	95.6	99.0	99.2
Operating income	8.73	16.4	18.6	19.1	20.6	22.1	24.0	26.7	25.8	26.0	28.9	30.7	31.4	36.8	34.8
Net income	73.8	19.5	13.2	51.5	23.7	17.2	45.6	24.2	19.0	19.4	109	21.1	15.4	19.2	17.6

Balance sheet

Annual · In mn (USD)

Total assets 565 mn Total liabilities 413 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total assets	371	383	373	429	459	525	490	484	489	494	598	608	596	581	565
Total liabilities	182	205	208	224	264	333	279	285	307	335	363	378	395	401	413
Equity	189	178	166	205	195	191	211	199	182	159	235	229	201	180	152

Cash flow

Annual · In mn (USD)

Operating 49.1 mn Investing -15.0 mn Financing -34.5 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	21.4	30.8	31.3	32.8	38.2	40.7	46.0	42.9	42.6	44.2	47.7	46.8	42.9	46.9	49.1
Investing	-3.28	-8.56	-13.5	-4.04	-44.3	-74.8	39.5	-7.96	-16.5	-27.2	-24.4	-36.7	-19.1	-13.9	-15.0
Financing	-7.43	-30.8	-17.5	-29.8	6.16	34.1	-86.0	-33.3	-25.1	-17.4	-6.54	-25.0	-23.2	-34.1	-34.5
Cash at period end	11.7	3.05	3.34	3.86	3.89	3.93	3.39	5.04	6.11	5.74	22.5	7.61	8.21	7.10	6.69

Profitability

Annual · %

Operating margin 35.0% Net margin 17.8%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating margin	29.6%	30.3%	34.2%	31.9%	32.3%	33.0%	33.2%	63.6%	42.7%	33.3%	34.3%	33.8%	32.8%	37.2%	35.0%
Net margin	250.2%	36.1%	24.3%	86.2%	37.0%	25.7%	63.0%	57.6%	31.5%	24.9%	129.7%	23.3%	16.1%	19.4%	17.8%

Returns & leverage

Annual · %

ROE 10.6% ROA 3.1% Debt ratio 73.0%

Show table：Returns & leverage

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	39.1%	10.6%	7.7%	27.9%	11.9%	8.9%	22.7%	11.8%	10.0%	11.4%	55.4%	9.1%	7.2%	10.1%	10.6%
ROA	19.9%	5.2%	3.5%	12.9%	5.3%	3.5%	9.0%	5.0%	3.9%	4.0%	20.0%	3.5%	2.6%	3.3%	3.1%
Debt ratio	49.1%	53.6%	55.6%	52.3%	57.5%	63.5%	57.0%	58.9%	62.8%	67.8%	60.7%	62.3%	66.3%	69.1%	73.0%

EPS

Annual · US$

EPS US$1.26

Show table：EPS

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	5.83	1.54	1.03	3.97	1.78	1.28	3.35	1.76	1.38	1.41	7.93	1.53	1.11	1.39	1.26

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read UNIVERSAL HEALTH REALTY INCOME TRUST (UHT) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.